Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients

Ahmed, Syed Imran and Khan, Shahzad (2020) Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients. Current Problems in Cardiology, 45 (9). p. 100648. ISSN 0146-2806

Full content URL:

Full text not available from this repository.

Item Type:Article
Item Status:Live Archive


The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Available data have suggested a possible multifactorial basis of these complications, and while efforts are being made to treat this infection, preventive measures with the use of systemic anticoagulation were quickly adopted to deal with this issue. Despite obvious benefits as appeared with the use of systemic anticoagulation, most of the emerged data were retrospective, hence raise questions on the possible interplay of the confounders as well as long-term benefits and safety of systemic anticoagulation.

Keywords:COVID-19, Coagulopathy, anticoagulation
Subjects:B Subjects allied to Medicine > B200 Pharmacology, Toxicology and Pharmacy
Divisions:College of Science > School of Pharmacy
ID Code:42963
Deposited On:17 Nov 2020 17:21

Repository Staff Only: item control page